1
Background: Sustaining clinical remission is an important treatment goal in moderate-to-severe UC.
2
A higher number of fistula tracts was associated with reduced clinical remission.
3
Thirty-three percent of infliximab treated patients maintained clinical remission at 3 years.
4
Radiological healing lagged behind clinical remission by a median of 12 months.
5
Clinicians should be careful about thrombosis even in patients at clinical remission.
6
The goal is to induce a clinical remission, thereby preventing radiographic deterioration.
7
Four patients had a clinical remission and seven showed no response.
8
She was started on a course of corticosteroid therapy which induced clinical remission.
9
In the following months, she achieved clinical remission except for low complement C3.
10
The majority of the sample was in clinical remission or reported minimal symptoms.
11
Relapse after clinical remission remains a leading cause of cancer-associated death.
12
Background: Understanding predictors of clinical remission would assist in clinical management of peanut allergy.
13
Eleven patients who reached clinical remission relapsed after treatment withdrawal.
14
Curiously, clinical remission was achieved after he resumed smoking, and colonoscopy revealed mucosal healing.
15
After five cycles of chemotherapy, we observed two complete responses and one clinical remission.
16
Results: Ninety-nine percent of patients achieved complete clinical remission.
